TECPR2 Gene SPG49 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The TECPR2 Gene SPG49 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations responsible for hereditary spastic paraplegia type 49. This advanced testing methodology utilizes next-generation sequencing technology to provide unparalleled accuracy in identifying genetic variations that impact motor neuron function and coordination.
What Does the TECPR2 Gene SPG49 Test Measure?
This sophisticated genetic analysis specifically targets the TECPR2 gene, which plays a critical role in autophagy and cellular maintenance processes within the nervous system. The test detects:
- Pathogenic variants and mutations in the TECPR2 gene
- Single nucleotide polymorphisms associated with SPG49
- Insertions, deletions, and copy number variations
- Complex genetic rearrangements affecting neurological function
Who Should Consider TECPR2 Genetic Testing?
This test is particularly recommended for individuals experiencing:
- Progressive muscle stiffness and spasticity in lower limbs
- Difficulty with walking and coordination (gait abnormalities)
- Family history of hereditary spastic paraplegia
- Unexplained neurological symptoms beginning in childhood or early adulthood
- Developmental delays with progressive motor impairment
- Suspected autosomal recessive inheritance patterns
Clinical Benefits of TECPR2 Gene Testing
Undergoing TECPR2 genetic testing provides numerous advantages for patients and healthcare providers:
- Accurate Diagnosis: Confirms or rules out SPG49 with high precision
- Early Intervention: Enables proactive management strategies
- Personalized Treatment: Guides targeted therapeutic approaches
- Family Planning: Provides crucial information for genetic counseling
- Prognostic Insights: Helps predict disease progression and outcomes
- Research Contribution: Advances understanding of rare neurological disorders
Understanding Your Test Results
Our comprehensive genetic counseling services help you interpret your TECPR2 test results:
- Positive Result: Indicates presence of pathogenic variants requiring specialized neurological care
- Negative Result: Suggests absence of tested mutations, though other genetic causes may exist
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Identifies individuals who may pass the condition to offspring
Test Pricing and Sample Requirements
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Turnaround Time: 3 to 4 Weeks
Sample Types Accepted: Blood, Extracted DNA, or One Drop Blood on FTA Card
Pre-Test Requirements
Before undergoing TECPR2 genetic testing, we recommend:
- Complete clinical history documentation
- Genetic counseling session with our specialists
- Development of detailed family pedigree chart
- Discussion of potential implications and outcomes
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.
Take Control of Your Neurological Health Today
Don’t let uncertainty about hereditary spastic paraplegia affect your quality of life. Our TECPR2 Gene SPG49 NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With advanced NGS technology and expert genetic counseling, we deliver reliable results you can trust.
Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and planning for the future.
